chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Nausea-Severe, Systemic: Vomiting-Severe, Additional Details: Patient just turned 12 so his second dose was the adult dose. His initial vaccine was with pediatric dose. Patient go light headed and nauseous and vomited. Once he vomited, he immediately felt better. He had some water and a snack size candy bar and laid on bench for a few minutes and was able to get back up and walk. He stated he felt better afterwards and the color was returned to his lips.
flu like symptoms; soreness and achiness; localized symptoms like pain, in the injection site; administered 1 dose of Moderna COVID-19 Vaccine to a patient on 20MAR2023 after the expiration date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered 1 dose of Moderna COVID-19 Vaccine to a patient on 20MAR2023 after the expiration date.), INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN (soreness and achiness) and VACCINATION SITE PAIN (localized symptoms like pain, in the injection site) in a 66-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 071B22A) for COVID-19 prophylaxis.     The patient's past medical history included COVID-19 (Again in Nov-2022 patient got COVID-19.) in October 2021.    On 20-Mar-2023, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 20-Mar-2023,  after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (administered 1 dose of Moderna COVID-19 Vaccine to a patient on 20MAR2023 after the expiration date.). On 21-Mar-2023, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN (soreness and achiness) and VACCINATION SITE PAIN (localized symptoms like pain, in the injection site). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered 1 dose of Moderna COVID-19 Vaccine to a patient on 20MAR2023 after the expiration date.), PAIN (soreness and achiness) and VACCINATION SITE PAIN (localized symptoms like pain, in the injection site) outcome was unknown and INFLUENZA LIKE ILLNESS (flu like symptoms) had not resolved.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  It is unknown if patient was under any concomitant or regular medication. No treatment was given.
Received DTaP (3rd dose) on 5/21/07 24 hours later, entire upper half of left arm was hot red and swollen to twice the size of normal. Treated by applying cool compresses - symptoms still exist unchanged the next day - subsiding on 5/24/07 - not entirely resolved.
redness, pain , swelling and warmth at site that progressed over several days.  became painful to lift left arm.  treated with antibiotic (keflex 500 tid for 10 d) and medrol dose pack, zyrtec and famotadine 40 at night
Initial report received from a healthcare professional on 20 February 2014. A 51-year-old female patient had received an intramuscular first dose of ADACEL, (batch number U4837AA) in left deltoid on 19 February 2014 at 11:30 hours. The patient had received previously first dose of MENOMUNE, (batch number, route and site of vaccination not reported) on 07 August 2002 and had experienced adverse event (unspecified). The patient had no illness at the time of vaccination and no pre-existing allergies or medical conditions. On 20 February 2014 at 10:30 hours, the patient felt weak, had chills, muscle aches, feverish and leg felt like "jelly" with dull ache. The patient's other medications include miscardis and nevsium (not legible). No laboratory tests were performed and corrective treatments were not reported. At the time of this report, the outcome was unknown. Documents held by sender: none.
Pt came in for pfizer covid bivalent booster but the pfizer covid monovalent vaccine was given inadvertently
Patient recieved Immunization at 1207 PM.  Immediately after vaccination was administered within left deltoid swelling within the injection site was severe enough to warrant nurses attention.  No signs of anaphylactic shock.  No shortness of breath/hives etc.  Just a firm sizable lump within injection site.  Size of lump was equivalent to a golfball.  Patient has full range of motion with left deltoid.
Arm pain; rash; itching, redness, swelling at injection site; diphenhydramine and methylprednisolone given.
One day after vaccine, patient had repetitive protrusion of tongue with eyes rolled backwards -> seen in ER and diagnosed with hypotonic hyporesponsive episode; no treatment, self-resolved in 1 day.
10/30/2021 I started experiencing cramping and heavy menstrual bleeding despite being on oral contraceptive continuously for the treatment of endometriosis. This was intermittent after the first week, which was constant. This continued for several weeks. The doctor tried increasing oral contraceptive and when that did not work, he prescribed a progesterone titrate. It continued to go away and then come back when I returned to my normal dose of oral contraceptive. This continued through February 2022. I was taking 4 pills a day. In March, I was able to go down to 3 pills a day. And, just now, I am down to one and am waiting to see if this works.
Sore arm; Symptoms kept on getting worse; Throat started closing up 15 to 20 minutes after the shot; Developed chills; Body aches/Body was aching really bad; Fever; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (Symptoms kept on getting worse), OROPHARYNGEAL DISCOMFORT (Throat started closing up 15 to 20 minutes after the shot), PAIN IN EXTREMITY (Sore arm), CHILLS (Developed chills) and MYALGIA (Body aches/Body was aching really bad) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes.    On 10-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Sep-2021, the patient experienced OROPHARYNGEAL DISCOMFORT (Throat started closing up 15 to 20 minutes after the shot), CHILLS (Developed chills) and PYREXIA (Fever). 10-Sep-2021, the patient experienced MYALGIA (Body aches/Body was aching really bad). On 11-Sep-2021, the patient experienced CONDITION AGGRAVATED (Symptoms kept on getting worse). On 12-Sep-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 12-Sep-2021, PYREXIA (Fever) had resolved. At the time of the report, CONDITION AGGRAVATED (Symptoms kept on getting worse), OROPHARYNGEAL DISCOMFORT (Throat started closing up 15 to 20 minutes after the shot) and CHILLS (Developed chills) outcome was unknown and PAIN IN EXTREMITY (Sore arm) and MYALGIA (Body aches/Body was aching really bad) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product information was provided. No treatment information was provided.
1/6/2022- Presentated to ER,chest pain, weakness, fatigue and cough. Afebrile. Troponin WNL. Chest X ray- No evidence of cardiopulmonary disease. Chest CT- No evidence of pulmonary embolism. 2L o2 via NC o2 sat at 99%. Started on Decadron, remdesivir, baricitinib, ceftriaxone, Xarelto and oral Doxycycline.  1/8/2022- No longer complains of chest pain troponin x3 negative. High 90's o2 sat on RA. Afebrile.  1/101/2022- Decadron d/c for no supplemental o2 needed.  1/11/2022- Patient afebrile and O2 sat above 95% on RA. Discharge to home.
Immediately after vaccination, a few red hive-looking rash spots appeared on my son's face/neck/arm and knee. Also, difficult to console crying a for a few hours, a few hours after vaccination. He received the Polio, Hib and Heb B vaccine today.
Swelling and soreness in the left armpit/lymph nodes for three days rolling second dose of Pfizer CV-19 vaccine. Cleared up until day 7 post vaccine when upon getting allergy shots in same arm (allergy shots for tree pollen and animal dander) soreness and swelling recurred.
Metallic taste in mouth, change in taste; Metallic taste in mouth, change in taste; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the arm left on 25Feb2021(at the age of 66-years-old) as a single dose for COVID-19 immunisation. The medical history were reported as none. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The  patient did not receive any medications within two weeks of vaccination. On 26Feb2021, the patient experienced metallic taste in mouth and change in taste. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events metallic taste in mouth and change in taste was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
she was hurting everywhere whole body, muscles arms legs; swollen neck left side down to shoulder; nauseous; can't eat, hard to swallow; feeling sick; every organ feels like it is inflamed; her stomach is doing numbers/stomach issues; Headache; she has no appetite; swelling has gone down in neck, the  swelling in my gut, underneath my boobs; This is a spontaneous report form a contactable consumer (patient). A 50-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EW0165) via unknown route of administration on 22Jul2021 18:00 as dose 2 single in left arm for COVID-19 immunization. Medical history included Bouts of Colitis (Scared that she has her Colitis Inflammed), Osteopenia, Nonalcoholic fatty liver disease all ongoing. Prior Vaccinations (within 4 weeks) were none. Concomitant medications were not reported. Patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: ER8733) on 01Jul2021 in left arm for COVID-19 immunization. It was reported that patient received her 2nd dose of the Pfizer covid-19 vaccine on Thursday, 22Jul2021, Friday evening she was hurting everywhere whole body, muscles arms legs, swollen neck left side down to shoulder, so nauseous and can't eat, hard to swallow feel like every organ was inflamed and her stomach was doing numbers, now Tuesday still feeling sick are these normal reactions or side effects and how long they should last? Should she go to the hospital? patient stated, that regarding her throat she was so nauseous she can't swallow and she has no appetite, not related to a restriction in her throat, just when she gets real nauseous. The swelling has gone down in neck, the swelling in my gut, underneath my boobs, I feel like everything was inflamed." patient stated it was persisting, especially the inflammation, headache, and stomach issues. Treatment received included Celebrex 200mg for inflammation, Zofran 8mg for nausea, 81mg Aspirin every night. The outcome of events was not recovered.  Follow-Up (05Aug2021): Follow-up attempts are completed. No further information is expected.
Patient felt dizzy and nauseated. Orange juice and water given, patient was brought to exam room laid on bed with legs elevated. Patient recovered and left with parent.
Welts, hives and red rash all over my body from my neck to my feet lasting for 48 hours and ended up with bruising on arms & legs
Large, red rash appeared on the right arm a few inches below the injection site exactly one week after receiving the vaccine. Hot to the touch, inflamed, and sore, the area redness continued to grow over the next 24 hours. It is now less hot and sore, but is still a large, swollen welt.
This spontaneous report was received from the registered nurse refers to an unknown number of patients of unknown age and gender. On an unknown date, the patient was vaccinated with RECOMBIVAX HB (dose, route and lot were not reported). On an unknown date, the patients received improperly stored   RECOMBIVAX HB. No adverse symptoms reported. At the time of the report the action was not reported. All telephone attempts to obtain follow-up information have been unsuccessful.  Additional information was received from a registered nurse concerning a 1 day male patient. Patient's birth weight was 7 lb 15 oz with 0 siblings. Patient was vaccinated with RECOMBIVAX HB the same day that he was born (22-MAY-2014) at 14:43 PM. Lot number J012520; Exp. Date: 30-JAN-2016.  The vaccine storage temp dropped to 0-1 degrees on 18 different episodes between May 14th and July 21st (unspecified year) according to min/max. All recorded temps are within 2-8 degrees. Additional information is not expected since all follow ups requested to complete the case were received.
Patient was given MMRV proquad which is not indicated for under 4 years old.
Tight & heavy chest, tingling left arm/hand for 24 hours occurred on the 2nd day after the 2nd COVID vaccine.   Sleeping with head elevated seemed to help.  Symptoms resolved by 1/11/21 in the mid-morning.
PATIENT C/O TIREDNESS, HEADACHE, DIAPHORIC AND STATED FEELING SHORT OF BREATH
soreness at vaccine site, mild headache, mild body aches and joint aches.  Symptoms began within a few hours of vaccine and remained through the day and into the next day.
This spontaneous report as received from a medical assistant refers to a six years old patient of unknown gender. On 17-JUL-2015, the patient was vaccinated with an improperly stored dose of VARIVAX (Merck) (dose and route were not reported, lot # reported as L007224, expiration date 03-MAR-2017). There were no adverse effects reported. This is one of several reports received from the same reporter. Lot L007224 has been verified to be a valid lot number for VARIVAX (Merck). Additional information has been requested.
I am reporting my symptoms through this avenue because the VAERS wouldn't let me complete my daily report on that day (no submit button found).  I had malaise a few hours after the shot. 12 hours after the shot, this turned into a fever that would peak at 103 within the next 12 hours. Fever was accompanied by severe chills, moderate headache, moderate muscle aches, mild joint aches, and mild nausea. I also had a swollen lymph node under my armpit ipsilateral to the injection, the diameter of a baseball. Discomfort from the lymph node was mild. The fever and chills were so bad that I couldn't do any daily activities and stayed in bed all day. I called a nurses line to ask them if I could take something for the discomfort and they advised Tylenol, so I took 1000 mg. Tylenol did bring down the fever to 101 and the fever rose back to 103, 9 hours after Tylenol. All the aforementioned symptoms lasted for 3 days, and the severe symptoms decreased in severity to "moderate" after about 36 hours.
Breakthrough COVID-19 case with symptom onset 8/18/2021: worsening confusion and loss of appetite. Hospitalized 8/26/2021-9/3/2021. Death 9/3/2021. Vital Records data not available yet
About nine days after the first Pfizer vaccine I noticed a pain in my left tooth where is was difficult to chew. I thought perhaps it was a cracked tooth or abscess but it spread throughout my mouth making it painful to chew any food. It seems that the nerves above the teeth were somehow infected or something. I had pain around my eyes and once in my left ear. I suspected Sinusitis or something but was not sure as I had never had this happen before. I had my dentist look at it. The metal tapping tool showed no cracks. The xrays showed no tooth problems, nor any sign of sinus inflammation.  I reported it to me doctor and he told me to report it on VAERS as a possible side effect of the vaccine. It was severe for about two weeks and has since returned to normal.
Vertigo constant head pressure till this day. Tingling fingers, ringing ears, aches, shortness of breath, fainting, EKG, MRI etc. Many school days missed.
Per patient, 1 day after received vaccine, he developed bright red streaking going up his arm,  and it went past his elbow, over 8 inches in length. Was warm to touch and tender. Also had nausea and vomiting 2 days after administration of vaccine.
Dose3: Moderna: 11/23/2021, 939909, I began to feel unwell on 03/22/2022 scratchy throat that and a cough presented on 03/24/2022; therefore, I took a home test on the 03/25/2022 that was positive. I then contacted by primary physician office to notify them of the COVID-19 positive home test and to received their directives for care. They went over the guidelines, guidelines that she could go out with the mask on 03/28/2022 and not to be indoor spaces without a mask, use mask in crowds until on April 1, 2022.
Client presented to the vaccination site on 11/04/2021. The client notified RN that he received a single dose of COVID-19 vaccine in another country on 4/21/2021. RN submitted a medical consult via text message to vaccine operations leads, requesting to proceed with the COVID-19 vaccine Janssen. Per CDC guidance, approval to proceed with COVID-19 vaccine Janssen was obtained from medical consult team via text message from lead vaccine operations. Client received COVID-19 vaccine Janssen Lot#1855194 on 11/04/2021. The client did not report any symptoms during the 15-minute observation period. RN educated client on possible adverse reactions and when to seek medical care.
Sleeplessness, Fatigue, Mental Fog, Muscle/Joint pains, Low Fever - Approximately 24 hours of symptoms.
Rash; Body pains; Muscle pains; Fever; This spontaneous case was reported by a non-health professional and describes the occurrence of RASH (Rash), MYALGIA (Body pains), MYALGIA (Muscle pains) and PYREXIA (Fever) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced RASH (Rash), MYALGIA (Body pains), MYALGIA (Muscle pains) and PYREXIA (Fever). At the time of the report, RASH (Rash) and PYREXIA (Fever) had resolved and MYALGIA (Body pains) and MYALGIA (Muscle pains) outcome was unknown.        Treatment information was not provided.  The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable.  On the night of the second dose (12Feb2021) patient started with fever, a rash, muscle and body pains.Sometimes, patient can't sleep because of the pains. Patient didn't contact with doctor to discuss the symptoms. Patient didn't take any medication to treat symptoms. Patient asks if it is normal for the side effects to last this long.
Vaccine was given one week past Best use date. Received 7/1/22 BUD should have been 9/9/22 and vaccine was given on 9/15/22
rash; This case was reported by a pharmacist via call center representative and described the occurrence of rash in a 63-year-old female patient who received Herpes zoster (Shingrix) (batch number 454S2, expiry date 5th November 2021) for prophylaxis.   On 1st August 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 5 months after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were received as follows: The reporter stated that the patient after vaccination had a spreading rash. No other details known at time of event. The reporter consented to follow up.
hives all over body on 2FEB93; pt given vax 1FEB93; afebrile; appetite as usual; playing on 2FEB93 in AM as usual;
got the flu shot, I was sick within 10 days; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via social media and was transmitted to sanofi on 10-Dec-2020.  This case involved a patient of unknown age and gender who got the flu shot and was sick within 10 days (illness), while he/she received vaccine INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.   Concomitant medications were unknown.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported for prophylactic vaccination.  On an unknown date, it was reported patient got the flu shot and was sick within 10 days (illness).   No laboratory data was reported.  It was not reported if the patient received a corrective treatment.  The event outcome was reported as Unknown for illness.  There will be no information available on the batch number for this case.
Several children, ages 6-16, vax w/ booster dose;  complained of stinging at inject site;  stinging lasted 1 minute.
Initial information received on 01-May-2019 regarding an unsolicited valid serious case received from a consumer. This case involves a male patient of unknown age who became paralyzed after receiving vaccine FLUZONE HIGH DOSE. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. In 2014, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (prefilled syringe 0.5 ml) lot U4809AA, exp date: 18-Jun-2014, via unknown route in unknown administration site. On an unknown date, following the vaccination the patient became paralyzed. This event was assessed as medically significant. Note: The reporter asked if Guillain Barre is listed in PI. It was not confirmed that the patient had GBS. (Other relevant tests included no lab data). Final diagnosis was paralysis. It was not reported if the patient received a corrective treatment. The outcome of the event was not reported at the time of reporting. List of documents held by sender: none. Sender's Comments: This case involves a male patient of unknown age who presented with paralysis (unspecified) after vaccination. Time to onset is unknown. More details regarding patient's medical history, previous vaccination history, etiological workup and investigation reports to identify alternative etiology are needed for complete assessment of the case. Based on the available information, the role of vaccine cannot be assessed.